In studies on human isolated peripheral airway smooth muscle; 1 A concentration dependent f,-adrenoceptor tachyphylaxis was observed to isoprenaline. 2 Cross desensitization to other fl-adrenoceptor agonists was demonstrated.
Introduction
Considerable controversy exists over the occurrence and importance off,-adrenoceptor desensitization in asthmatic patients. A number of clinical reports have suggested that adrenergic bronchodilator aerosols may lead to a refractory state if they are used excessively (Keighley, 1966; Van Metre, 1969) . Several clinical studies have provided data relevant to this problem, but the results have been conflicting. Thus, Choo-Kang, Simpson & Grant (1969) noted a diminution in response to inhaled salbutamol with repeated administration in asthmatic patients. Paterson, Courtnay Evans & Prime (1971) observed a marked rebound bronchoconstriction in 4 out of 15 asthmatics following a prolonged infusion of isoprenaline. Jenne, Strickland, Chick & Wall (1976) have observed a diminished fl-adrenoceptor response in patients treated for long periods with terbutaline. In normal subjects, Holgate, Baldwin & Tattersfield (1977) demonstrated a waning bronchodilator response to inhalations of salbutamol during a 4 week period of exposure to that drug.
In contrast to these observations, Larsson, Svedmyr & Theringer (1974) demonstrated tachyphylaxis with respect to muscle tremor, but not to bronchodilator response in patients treated for 3 months with oral terbutaline 15 mg daily. Other authors, reporting similar long term studies in patients receiving adrenergic bronchodilators, have also concluded that no significant desensitization to their effects occurs (Formgren, 1976; Gibson, Tattersfield & Pride, 1972 (Conolly, Davies, Dollery & George, 1971; Benoy, El-Fellah, Schenider & Wace, 1976; Spilker & Tyll, 1976) .
Thus there is a pressing need for studies in human isolated tissues to evaluate the extent of the occurrence of fl-adrenoceptor desensitization, in order to evaluate its importance in bronchial asthma. This approach permits study under controlled conditions, free from artefacts such as concomitant administration of other drugs and devoid of problems caused by day to day variation in severity of underlying disease (asthma) (Tinkelman, Avner & Cooper, 1977) , and avoids the difficulties of The tissues were allowed to equilibrate under these conditions for 60-90 min before any drugs were added. At the end of this time, the positions of the transducers were adjusted to restore the transducer arms to the horizontal position. The strips were then contracted with histamine, using a range of concentrations (10-9 to 10-4 mol 1-') to produce a cumulative dose-response curve, and to establish for each tissue, the concentration (EC90) of histamine required to produce 90% of the maximum attainable contraction. The 90% response was used as the contraction against which f,-adrenoceptor agonists could be tested. In a separate study, it was shown that the contractile response to any given concentration of histamine was fully maintained for at least 45 min. Using the EC90 generated contraction, a cumulative dose-response relaxation curve for isoprenaline was then obtained. The next step in the procedure was the attempt to produce fl-adrenoceptor desensitization.
The tissues were once more washed and were then incubated with isoprenaline 10-6 or 4 x 10 -4 mol 1-1 for I h. Therafter, the tissues were washed and allowed to re-equilibrate for h in drug-free KrebsHenseleit solution. Following this, the original EC90 of histamine was added to the bath and a further isoprenaline dose-response curve was generated. At the end of this second dose-response curve, EDTA (4 mg/ml, final concentraion) was added to some of the baths to bring about full relaxation of the tissues in order to demonstrate that a comparable degree of contraction had been present at the start of both preand post-incubation dose response curves (Figure 1 ).
Cumulative dose-response expressed as a percent of the maximal isoprenaline (10-s mol 1-1) response curves for noradrenaline, adrenaline and salbutamol were also examined before and after incubation with isoprenaline. The response of each strip to these agents before and after isoprenaline incubation was expressed as a percent of the pre-isoprenaline incubation response to isoprenaline l0-5 mol l-1.
The pre-and post-incubation dose-response curves of strips from 15 lungs were compared, by t-test, and compared with the control response of strips from the same lung not incubated in isoprenaline with doseresponse curves of control strips obtained from the same lung, but which had been incubated for the one hour period in Krebs-Henseleit solution without isoprenaline.
In addition, 3 of the 6 strips from each of 15 separate lungs were incubated overnight and for the duration of the above protocol, with hydrocortisone (1.5x10-4 moll 1)
In some of the experiments, the muscle strips were repeatedly washed after the post-incubation doseresponse curve, and then left for a further hour to assess the degree of recovery of j3-adrenoceptor responsiveness.
In a further series of experiments, the effect of a persistent low concentration of isoprenaline (10-9 mol`1) on restoration of responsiveness during the 'recovery' phase, was examined in muscle from 3 lungs.
In an attempt to define the mechanism of tachyphylaxis, we measured cyclic AMP generation in bronchial strips from 3 lungs, using a modified
Gilman method, as previously described (Conolly & Greenacre, 1977 in the isoprenaline treated bronchi, muscle strips from 6 lungs were examined. PDE activity was measured by the technique of Thompson & Appleman (1971) as modified by Greenacre, Schofield & Conolly (1978) . Bronchial muscle strips, again incubated either in Krebs-Henseleit solution alone, or with isoprenaline 4 x 10-i mol I1-for 1 h were homogenized and centrifuged. Aliquots of the supernatant were taken for PDE assay. Comparison of PDE activity between control and isoprenaline treated bronchi (expressed as nmol cyclic AMP hydrolyzed mg-1 protein 15 min-') was made after the data had been corrected for protein content, by the method of Lowry, Rosebrough, Farr & Randall (1951) . Statistical methods used were the pair and unpaired t-test where not specified.
Results
The group of bronchial strips showed a spectrum of susceptibility to desensitization induced by isoprenaline 10-6 mol I-'. Between patients there was a wide and significant variation in the susceptibility of bronchi to desensitization (P < 0.05); but the variation between strips within the same lung was not significant (P> 0.10) on two way analysis of variance.
In contrast, following the 4x 10-4 mol 1-' isoprenaline incubation, desensitization was uniformly present in all lungs studies. One hour after the 10-6 mol 1 ' isoprenaline incubation the maximal isoprenaline response (mean value for all tissues studied) was 78.5% of the control response, whereas after 4 x 10 -mol I -' isoprenaline it was reduced to 22.l1% (Table 1, Figure 1 ).
Whe the bronchial strips were relaxed with other /3-adrenoceptor agonists (adrenaline, noradrenaline, salbutamol) 1 h after incubation with 4 x 10-4 mol I-' isoprenaline marked attenuation of response was noted, indicating the development of cross tachyphylaxis to other /3-adrenoceptor agonists (Table 2) .
In those strips that were washed repeatedly and left for 2.5 h after the incubation, there was a partial recovery of responsiveness. The degree of recovery in those strips incubated with hydrocortisone was more significant (P < 0.05, n = 6) than those strips bathed in Krebs-Henseleit solution alone (P > 0. 1, n = 6). The Table 1 Desensitization of bronchial smooth muscle by incubation with isoprenaline 10 6 and 4 x I0-4 mol [1 for 1 h. Values given are % of maximal relaxation (mean + s.e. mean) induced by isoprenaline prior to desensitization (n= 15 lungs). -. (Table 3) . Bronchial wall cyclic AMP response to isoprenaline (10 8 and 10 6 mol 1 ') was significantly blunted by the prior isoprenaline (4x 10 -mol 1 -) incubation (P<0.05, n=4), there being a roughly three-fold decrease in response (Table 4) . Total bronchial wall cyclic AMP phosphodiesterase activity was not altered significantly (t-0.57, y =5, P> 0.7), (Table 5) .
Discussion
In these experiments, we have demonstrated a concentration dependent desensitization by isoprenaline, of the /?-adrenoceptor mechanism in human peripheral bronchial smooth muscle. A similar phenomenon has been observed in other species, notably the dog (Avner & Jenne, 1977) and guinea pig (Benoy et al., 1976) . In the rat, however, for technical reasons, such evidence has been difficult to obtain (Fleisch & Titus, 1972) . It has also proved difficult to demonstrate desensitization convincingly in vivo in asthmatics treated with low doses of /Badrenergic receptor bronchodilator drugs. This may be for many reasons, including the doses used, the inherent variability of the disease and the insensitivity of many spirometric tests used to measure airway function. Using body plethysmography, Holgate et al. (1977) have shown a dose and time related decrease in bronchodilator responsiveness in normal subjects. Large doses of adrenergic drugs appear to impair bronchodilator function seriously in some subjects (Keighley, 1966; Van Metre, 1969; Paterson et al., 1971) .
Our data show (most markedly at the lower isoprenaline incubation concentration of 10-6 mol I-) that there is considerable variation in the interindividual susceptibility to desensitization. A clinical implication of this observation is that there might be subsets of the asthmatic population particularly liable to develop such resistance. The elimination of a portion of the asthmatic population by means of some constitutional abnormality has already been proposed as an explanation for the rise and fall of the United Kingdom asthma death rate in the 1960's (Inman, 1974) .
The mechanism of this desensitization remains obscure. There appears to be a fairly readily reversible component since bronchial strips incubated with isoprenaline 4 x 10 mol 1-1 had recovered over 60% of their original responsiveness within 3 h.
Glucocorticoids appear to enhance this reversibility in that treatment with hydrocortisone was associated with a return to full responsiveness within 3 h.
Relaxation of smooth muscle is presumably a cyclic AMP dependent phenomenon, and we have demonstrated that the desensitization produced by isoprenaline incubation is associated with a reduced cyclic AMP response in the peripheral bronchial wall to isoprenaline, as observed in guinea pig, by ElFellah, Marshall & Turnbull (1976) . However, the reason for this diminution has not been elucidated. We have demonstrated that it cannot apparently be attributed to changes in phosphodiesterase activity. One cannot, however, exclude this possibility, since a local isoenzyme may be increased with no overall PDE activity change being demonstrable (Weiss & Hait, 1977) . The most likely alternative mechanisms would therefore seem to be some derangement of the f,-receptor-adenylate cyclase unit, or reduction of (Logsdon, Middleton & Coffey, 1972 (Kariman & Lefkowitz, 1977) and the suggestion has been made that this may be due to the formation of a stable receptor-agonist complex (Williams & Lefkowitz, 1977) . The ability of a persisting, but very low concentration of isoprenaline to prevent recovery so strikingly has previously been observed in fibroblasts (Morrison et al., 1973) and has been presumed to indicate continuing inactivation or destruction of new receptor sites as they are formed to replace those lost during desensitization. If such an interpretation is correct, the inability of cycloheximide to delay recovery is rather surprising, the concentration used being adequate to reduce protein synthesis by about 90% (Browning, Brostrom & Groppi, 1976) .
